MedPath

Linco-spectin 100 Soluble Powder

Registration Number: MAL16010004HA

Approved
Approval ID

b7b7488bf56c6ddb

Registration Number

MAL16010004HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

150.00 mcg/mLAvailable
Package Size: 150.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

SPECTINOMYCIN SULFATEActive
Monograph: spectinomycin sulfate
LINCOMYCIN HCLActive
Monograph: lincomycin hcl

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Linco-spectin 100 Soluble Powder - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform